Abstract
Complex carbohydrates, which are major components of the cell membrane, perform important functions in cell-cell and cell-extracellular matrix interactions, as well as in signal transduction. They comprise three kinds of biomolecules: glycoproteins, proteoglycans and glycosphingolipids. Recent studies have also shown that glycan changes in malignant cells take a variety of forms and mediate key pathophysiological events during the various stages of tumour progression. Glycosylation changes are universal hallmarks of malignant transformation and tumour progression in human cancer, which take place on the whole cells or some specific molecules. Accordingly, those changes make them prominent candidates for cancer biomarkers in the meantime. This review mainly focuses on the correlation between glycosylation and the metastasis potential of tumour cells from comprehensive aspects to further address the vital roles of glycans in oncogenesising. Moreover, utilizing these glycosylation changes to ward off tumour metastasis by means of anti-adhesion approach or devising anti-cancer vaccine is one of promising targets of future study.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CRD:
-
carbohydrate recognition domain
- DP:
-
degree of polymerization
- EMT:
-
epithelial-mesenchymal transition
- FAO:
-
Food and Agriculture Organization
- HCC:
-
hepatocellular carcinoma
- NGSH:
-
N-(α-d-glucopyranoside) salicyloyl hydrazine
- GSK:
-
glycogen synthase kinase
- GLP:
-
glyco-lipopeptide
- GSL:
-
glycosphingolipids
- GPI:
-
glycosphosphatidylinositol
- GPAA1:
-
GPI anchor attachment protein 1
- GSK:
-
glycogen synthase kinase
- HCC:
-
hepatocellular carcinoma
- AHSG:
-
α2-HS glycoprotein
- MHC:
-
major histocompatibility complex
- MMPs:
-
matrix metalloproteinases
- PECAM:
-
platelet endothelial cell adhesion molecule
- PSA:
-
prostate-specific antigen
- WHO:
-
World Health Organization
References
Ariga T, Suetake K, Nakane M, Kubota M, Usuki S, Kawashima I and Yu R K 2009 Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors; Neurosignals 17 226–234
Arnold J N, Saldova R, Hamid U and Rudd P M 2008 Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation; Proteomics 8 3284–3293
Azab A K, Kleinstern J, Srebnik M and Rubinstein A 2008 The metastatic stage-dependent mucosal expression of sialic acid is a potential marker for targeting colon cancer with cationic polymers; Pharm. Res. 25 379–386
Bektas M and Spiegel S 2003 Glycosphingolipids and cell death; Glycoconjugate J. 20 39–47
Bettahi I, Dasgupta G, Renaudet O, ChentoufiA A, Zhang X L, Carpenter D, Yoon S, Dumy P and BenMohamed L 2009 Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4(+) nd CD8(+) T cell epitopes; Cancer Immunol. Immun. 58 187–200
Brockhausen I 1999 Pathways of O-glycan biosynthesis in cancer cells; Bba-Gen Subjects 1473 67–95
Buskas T, Thompson P and Boons G J 2009 Immunotherapy for cancer: synthetic carbohydrate-based vaccines; Chem. Commun. No. 36, 5335–5349
Ceaglio N, Etcheverrigaray M, Conradt H S, Grammel N, Kratje R and Oggero M 2010 Highly glycosylated human alpha interferon: An insight into a new therapeutic candidate; J. Biotechnol. 146 74–83
ChentoufiA A, Nesburn A B and BenMohamed L 2009 Recent advances in multivalent self adjuvanting glycolipopeptide vaccine strategies against breast cancer; Arch. Immunol. Ther. Ex. 57 409–423
Contessa J N, Bhojani M S, Freeze H H, Ross B D, Rehemtulla A and Lawrence T S 2010 Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy; Clin. Cancer Res. 16 3205–3214
Cummings J H and Stephen A M 2007 Carbohydrate terminology and classification; Eur. J. Clin. Nutr. 61Suppl. 1 S5–S18
Dabelsteen E 1996 Cell surface carbohydrates as prognostic markers in human carcinomas; J Pathol. 179 358–369
Deguchi T, Tanemura M, Miyoshi E, Nagano H, Machida T, Ohmura Y, Kobayashi S, Marubashi S et al. 2010 Increased immunogenicity of tumor-associated antigen, Mucin 1, engineered to EXPRESS alpha-Gal epitopes: a novel approach to immunotherapy in pancreatic cancer; Cancer Res. 70 5259–5269
Demers M, Rose A, Grosset A A, Biron-Pain K, Gaboury L, Siegel P M and St-Pierre Y 2010 Overexpression of galectin-7, A myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells; Am. J. Pathol. 176 3023–3031
Dennis J W, Granovsky M and Warren C E 1999 Glycoprotein glycosylation and cancer progression; BBA-Gene Subjects 1473 21–34
Dwek M V and Brooks S A 2004 Harnessing changes in cellular glycosylation in new cancer treatment strategies; Curr. Cancer Drug Tar. 4 425–442
FAO 1998 Carbhohydrates in human nutrition, Food and Agriculture Organization of the United Nations, Rome; Report of a Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper no. 66
Fuster M M and Esko J D 2005 The sweet and sour of cancer: Glycans as novel therapeutic targets; Nat. Rev. Cancer 5 526–542
Gallegos B, Perez-Campos E, Martinez R, Leyva P, Martinez M, Hernandez R, Pina S, Hernandez C, Zenteno E and Hernandez P 2010 O-glycosylation expression in fibroadenoma; Prep. Biochem. Biotech. 40 1–12
Garcea G, Manson M M, Neal C P, Pattenden C J, Sutton C D, Dennison A R and Berry D P 2007 Glycogen synthase kinase-3 beta; A new target in pancreatic cancer? Curr. Cancer Drug Tar. 7 209–215
Gilbert S F 2009 Ageing and cancer as diseases of epigenesis; J. Biosci. 34 601–604
Goswami K, Nandeesha H, Koner B and Nandakumar D 2007 A comparative study of serum protein-bound sialic acid in benign and malignant prostatic growth: possible role of oxidative stress in sialic acid homeostasis; Prostate Cancer P. D. 10 356–359
Gu J, Sato Y, Kariya Y, Isaji T, Taniguchi N and Fukuda T 2009 A mutual regulation between cell-cell adhesion and N-glycosylation: Implication of the bisecting GlcNAc for biological functions; J. Proteome Res. 8 431–435
Hakomori S I 2008 Structure and function of glycosphingolipids and sphingolipids: Recollections and future trends; BBA-Gene Subjects 1780 325–346
Hakomori S 2010 Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility; FEBS Lett. 584 1901–1906
He X T, Hannocks M J, Hampson I and Brunner G 2002 GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy; Clin. Exp. Metastas. 19 291–299
Hebbar M, Adenis A, Revillion F, Duhamel A, Romano O, Truant S, Libersa C, Giraud C et al. 2009 E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer; Eur. J. Cancer 45 1871–1876
Hedlund M, Ng E, Varki A and Varki N M 2008 alpha 2–6-linked sialic acids on N-glycans modulate carcinoma differentiation in vivo; Cancer Res. 68 388–394
Hoessli D C, Tauzin S, Nasir-ud-Din and Borisch B 2007 Functional and structural roles of GPI moieties in mammalian plasma membranes; Curr. Org. Chem. 11 619–626
Honda S, Suzuki S and Taga A 2003 Analysis of carbohydrates as 1-phenyl-3-methyl-5-pyrazolone derivatives by capillary/microchip electrophoresis and capillary electrochromatography; J. Pharmaceut. Biomed. 30 1689–1714
Huang G C and Chen L B 2010 Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma; J. Cancer Res. Clin. 136 1201–1211
Iacovazzi P A, Notarnicola M, Caruso M G, Guerra V, Frisullo S, Altomare D F and Correale M 2010 Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients; Immunopharm. Immunot. 32 160–164
Igarashi Y and Kannagi R 2010 Glycosphingolipids as mediators of phenotypic changes associated with development and cancer progression; J. Biochem. 147 3–8
Jiang W W, Zahurak M, Zhou Z T, Park H L, Guo Z M, Wu G J, Sidransky D, Trink B and Califano J A 2007 Alterations of GPI transamidase subunits in head and neck squamous carcinoma; Mol. Cancer 6 74
Jian-Hua T, Wang-Jiao H, He H, Chao-Chao T, Qiong D, Kai-Jia W, Xian-Yu Y and Xu-Jin Z 2009 Important roles of glycosyl phosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma; Clin. Biochem. 42 400–407
Ju T Z, Lanneau G S, Gautam T, Wang Y C, Xia B Y, Stowell S R, Willard M T, Wang W Y et al. 2008 Human tumor antigens to and sialyl Tn arise from mutations in Cosmc; Cancer Res. 68 1636–1646
Kaiser A, Gaidzik N, Westerlind U, Kowalczyk D, Hobel A, Schmitt E and Kunz H 2009 A synthetic vaccine consisting of a tumor-associated sialyl-T-N-MUC1 tandem-repeat glycopeptide and tetanus toxoid: induction of a strong and highly selective immune response; Angew. Chem. Int. Edit. 48 7551–7555
Kazezoglu C, Gokmen S S, Sunar B, Aygit C and Cakir B 2007 Serum total and lipid bound sialic acid levels in patients with benign and nonmelanom malignant skin tumors; Turk. J. Biochem. 32 17–21
Kim S J, Choi I J, Cheong T C, Lee S J, Lotan R, Park S H, and Chun K H 2010 Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression; Gastroenterology 138 1035–1308
Kim Y S, Yoo H S and Ko J H 2009 Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery; Protein Peptide Lett. 16 499–507
Kitazume S, Imamaki R, Ogawa K, Komi Y, Futakawa S, Kojima S, Hashimoto Y, Marth J D, Paulson J C and Taniguchi N 2010 Alpha 2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling; J. Biol. Chem. 285 6515–6521
Knas M, Szajda S D, Snarska J, Zalewska-Szajda B, Walejko P, Borzym-Kluczyk M, Knas-Karaszewska K, Kepka A et al. 2009 Colon Cancer Releases alpha-Tocopherol from Its O-Glycosides Better Than Normal Colon Tissue; Hepato-Gastroenterol. 56 339–342
Laderach D J, Compagno D, Toscano M A, Croci D O, Dergan-Dylon S, Salatino M and Rabinovich G A 2010 Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings; Iubmb Life 62 1–13
Lahiri S and Futerman A H 2007 The metabolism and function of sphingolipids and glycosphingolipids; Cell Mol. Life Sci. 64 2270–2284
Laubli H, Stevenson J L, Varki A, Varki N M and Borsig L 2006 L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest; Cancer Res. 66 1536–1542
Le Mercier M, Fortin S, Mathieu V, Kiss R and Lefranc F 2010 Galectins and gliomas; Brain Pathol. 20 17–27
Li L M, Ching W K, Yamaguchi T and Aoki-Kinoshita K F 2010 A weighted q-gram method for glycan structure classification; BMC Bioinformatics 11Suppl. 1 S33
Liakatos A and Kunz H 2007 Synthetic glycopeptides for the development of cancer vaccines; Curr. Opin. Mol. Ther. 9 35–44
Liang P H, Wu C Y, Greenberg W A and Wong C H 2008 Glycan arrays: biological and medical applications; Curr. Opin. Chem. Biol. 12 86–92
Marth E, Flaschka G, Stiegler S and Mose J 1988 Sialic acid as a marker for differentiation between benign and malignant intracranial tumors; Clin. Chim. Acta 176 251–258
Mayoral M A, Mayoral C, Meneses A, Villalvazo L, Guzman A, Espinosa B, Ochoa J L, Zenteno E and Guevara J 2008 Identification of Galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain; Cancer Invest. 26 615–623
McCluskey K, Wiest A and Plamann M 2010 The Fungal Genetics Stock Center: a repository for 50 years of fungal genetics research; J. Biosci. 35 119–126
Meyts E, Poll S N, Goukasian I, Jeanneau C, Herlihy A S, Bennett E P, Skakkebaek N E, Clausen H, Giwercman A and Mandel U 2007 Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation; Virchows Arch. 451 805–814
Mi D H, Gao Y G, Zheng S, Ba X Q and Zeng X L 2009 Inhibitory effects of chemically modified heparin on the P-selectinmediated adhesion of breast cancer cells in vitro; Mol. Med. Reports 2 301–306
Nagao K, Itoh Y, Fujita K and Fujime M 2007 Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes; Int. J. Urol. 14 795–799
Ohtsubo K and Marth J D 2006 Glycosylation in cellular mechanisms of health and disease; Cell 126 855–867
Oyelaran O and Gildersleeve J C 2007a Application of carbohydrate array technology to antigen discovery and vaccine development; Expert Rev. Vaccines 6 957–969
Patsos G, Hebbe-Viton V, Robbe-Masselot C, Masselot D, Martin R S, Greenwood R, Paraskeva C, Klein A et al. 2009 O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines; Glycobiology 19 382–398
Peracaula R, Barrabes S, Sarrats A, Rudd P M and de Llorens R 2008 Altered glycosylation in tumours focused to cancer diagnosis; Dis. Markers 25 207–218
Pinho S S, Osorio H, Nita-Lazar M, Gomes J, Lopes C, Gartner F and Reis C A 2009 Role of E-cadherin N-glycosylation profile in a mammary tumor model; Biochem. Biophs. Res. Commun. 379 1091–1096
Pizette S, Rabouille C, Cohen S M and Therond P 2009 Glycosphingolipids control the extracellular gradient of the Drosophila EGFR ligand Gurken; Development 136 551–561
Rabinovich G A, Toscanol M A, Jackson S S and Vasta G R 2007 Functions of cell surface galectin-glycoprotein lattices; Curr. Opin. Struc. Biol. 17 513–520
Radichev I A, Remacle A G, Shiryaev S A, Purves A N, Johnson S L, Pellecchia M and Strongin A Y 2010 Biochemical characterization of the cellular glycosylphosphatidylinosito l-linked membrane type-6 matrix metalloproteinase; J. Biol. Chem. 285 16076–16086
Reis C A, Osorio H, Silva L, Gomes C and David L 2010 Alterations in glycosylation as biomarkers for cancer detection; J. Clin. Pathol. 63 322–329
Rose A, Grosset A A, Dong Z F, Russo C, MacDonald P A, Bertos N R, St-Pierre Y, Simantov R et al. 2010 Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer; Clin. Cancer Res. 16 2147–2156
Rudd P M, Elliott T, Cresswell P, Wilson I A and Dwek R A 2001 Glycosylation and the immune system; Science 291 2370–2376
Sattler U, Hirschhaeuser F and Mueller-Klieser W F 2010 Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy? Curr. Med. Chem. 17 96–108
Scatena R, Bottoni P, Pontoglio A, Mastrototaro L and Giardina B 2008 Glycolytic enzyme inhibitors in cancer treatment; Expert Opin. Inv. Drug. 17 1533–1545
Sozzani P, Arisio R, Porpiglia M and Benedetto C 2008 Is sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer? Int. J. Surg. Pathol. 16 365–374
Sun Q, Weber C R, Sohail A, Bernardo M M, Toth M, Zhao H, Turner J R and Fridman R 2007 MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties; J. Biol. Chem. 282 21998–22010
Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M and Kannagi R 1993 Contribution of carbohydrate antigens Sialyl Lewis-A and Sialyl Lewis-X to adhesion of human cancer-cells to vascular endothelium; Cancer Res. 53 354–361
Tang C K, Katsara M and Apostolopoulos V 2008 Strategies used for MUC1 immunotherapy: human clinical studies; Expert Rev. Vaccines 7 963–975
Thomas S N, Schnaar R L and Konstantopoulos K 2009 Podocalyxinlike protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells; Am. J Physiol.-Cell Physiol. 296 C505–C513
Tietze L F, von Hof J M, Krewer B, Mueller M, Major F, Schuster H J, Schuberth I and Alves F 2008 Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy; Chemmedchem 3 1946–1955
Ugorski M and Laskowska A 2002 Sialyl Lewis(a): a tumorassociated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells; Acta Biochim. Pol. 49 303–311
Varki A, Kannagi R and Toole B P 2009 Glycosylation changes in cancer; in Essentials of glycobiology, 2nd edition, (eds.) A Varki, R D Cummings, J D Esko, H H Freeze, P Stanley, C R Bertozzi, G W Hart and M E Etzler (New York: Cold Spring Harbor Laboratory Press) pp 580–670
Varki N M and Varki A 2007 Diversity in cell surface sialic acid presentations: implications for biology and disease; Lab. Invest. 87 851–857
Waetzig G H, Chalaris A, Rosenstiel P, Suthaus J, Holland C, Karl N, Uriarte L V, Till A et al. 2010 N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130; J. Biol. Chem. 285 1781–1789
Wang F L, Cui S X, Sun L P, Qu X J, Xie Y Y, Zhou L, Mu Y L, Tang W and Wang Y S 2009 High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer; Cancer Detect. Prev. 32 437–443
Wang L Y, Liang Y L, Li Z X, Cai X M, Zhang W, Wu G Q, In J W, Fang Z Y, Yang Y and Zha X L 2007 Increase in beta 1–6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta 1 stability in human hepatocellular carcinoma cell line SMMC-7721; J. Cell Biochem. 100 230–241
Witz I P 2008 The selectin-selectin ligand axis in tumor progression; Cancer Metast. Rev. 27 19–30
Wu M H, Hong T M, Cheng H W, Pan S H, Liang Y R, Hong H C, Chiang W F, Wong T Y et al. 2009 Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons; Mol. Cancer Res. 7 311–318
Wu Y M, Nowack D D, Omenn G S and Haab B B 2009 Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells; J. Proteome Res. 8 1876–1886
Xu Y, Zhang L and Hu G X 2009 Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis; Biologicals 37 18–25
Yeung S J, Pan J and Lee M H 2008 Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer; Cell Mol. Life Sci. 65 3981–3999
Yi J K, Chang J W, Han W, Lee J W, Ko E, Kim D H, Bae J Y, Yu J et al. 2009 Autoantibody to Tumor Antigen, Alpha 2-HS Glycoprotein: A Novel Biomarker of Breast Cancer Screening and Diagnosis; Cancer Epidem. Biomar. 18 1357–1364
Yusa A, Miyazaki K, Kimura N, Izawa M and Kannagi R 2010 Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewis(x) expression and accelerates Proliferation of Colon Cancer Cells; Cancer Res. 70 4064–4073
Zarbock A, Polanowska-Grabowska R K and Ley K 2007 Plateletneutrophil-interactions: Linking hemostasis and inflammation; Blood Rev. 21 99–111
Zavareh R B, Lau K S, Hurren R, Datti A, Ashline D J, Gronda M, Cheung P, Simpson C D et al. 2008 Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function; Cancer Res. 68 6688–6697
Zen K, Liu D Q, Guo Y L, Wang C, Shan J, Fang M, Zhang C Y and Liu Y 2008 CD44v4 Is a major E-selectin ligand that mediates breast cancer cell transendothelial migration; PLOS One 3 e1826
Zhang G, Zhang H T, Wang Q, Lal P, Carroll A M, de la Llera-Moya M, Xu X W and Greene M I 2010 Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker; Proc. Nat. Acad. Sci. USA 107 732–737
Zhao F S, Dou J, He X F, Wang J, Chu L L, Hu W H, Yu F L, Hu K, Wu Y and Gu N 2010 Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model; Vaccine 28 2846–2852
Zhao Y Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J G and Taniguchi N 2008a Branched N-glycans regulate the biological functions of integrins and cadherins; FEBS J. 275 1939–1948
Zhao P, Wang M, Zhang S P, Shao S C, Sun X Y, Yao S D and Wang S L 2008b Photochemical properties of a new kind of anti-cancer drug: N-glycoside compound; Sci. China Ser. B 51 872–877
Author information
Authors and Affiliations
Corresponding author
Additional information
Equal contribution
Rights and permissions
About this article
Cite this article
Li, M., Song, L. & Qin, X. Glycan changes: cancer metastasis and anti-cancer vaccines. J Biosci 35, 665–673 (2010). https://doi.org/10.1007/s12038-010-0073-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-010-0073-8